18168-Leukemia-AML-1269

Leukemia

A Phase 3b, Single-Arm, Multicenter Open-Label Study of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in AML Patients Ineligible for Intensive Chemotherapy (M19-072)

  • Details

ClinicalTrials.gov ID: NCT03941964
Diagnosis Type: AML
USOR Number:

  • Address

11850 Blackfoot St NW, Suite 100
Coon Rapids, MN 55433
P: (763) 712-2100

Search by practice name, trial titles, indicators and specific disease types.